The growth of Indonesia’s middle class has resulted in an increasing demand for branded pharmaceuticals. However, efforts to attract additional foreign investment into the pharmaceuticals industry are hampered by an array of challenges, including price controls, weak intellectual property (IP) law enforcement, corruption, lack of skilled labour and...